Intraoperative Bleeding During Endoscopic Sinus Surgery
- Registration Number
- NCT01014728
- Lead Sponsor
- University of Chicago
- Brief Summary
The purpose of this study is to compare the blood loss during sinus surgery looking at two different types of anesthesia: either intravenous anesthesia with propofol or inhalational anesthesia with sevoflurane.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 33
- male or female patients who are 18 years of age or older,
- ASA grade 1 (normal otherwise healthy patient),
- ASA grade 2 (patient with mild systemic disease),
- patients who have chronic sinusitis with or without nasal polyps.
- pregnancy,
- abnormal coagulation panel
- preoperative use of NSAIDS or ASA medications within 7 days,
- end-stage renal disease,
- allergy to any of the used medications,
- maximal body mass index over 35
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intravenous anesthesia propofol Intravenous anesthesia with propofol for endoscopic sinus surgery Inhalation anesthesia sevoflurane Inhalation anesthesia with sevoflurane for endoscopic sinus surgery
- Primary Outcome Measures
Name Time Method Estimated Blood Loss from the start of surgery to the end of surgery, up to 6 hours Estimated blood loss in milliliters per hour is calculated by subtracting the volume of total irrigation used during the case from the total amount of fluid in the suction canister at the end of surgery and dividing by surgical time in hours.
- Secondary Outcome Measures
Name Time Method Anesthesiologist Numeric Rating Scale (ANRS) at the end of surgery (up to 6 hours) The anesthesiologist numeric rating scale is to rate the ease of the anesthesia technique ranging from 0 to 10 (10 is best, 0 is worst).
Surgeon's Numeric Rating Scale (SNRS) at the end of surgery (up to 6 hours) The surgeon's numeric rating scale(SNRS)is to rate the surgical conditions (mucosal bleeding and visibility) on a scale ranging from 0 to 10, with 0 defined as cadaveric conditions and 10 as severe bleeding requiring constant suction.
Trial Locations
- Locations (1)
The University of Chicago
🇺🇸Chicago, Illinois, United States